Diabetes, Vol 42, Issue 6 826-832, Copyright © 1993 by American Diabetes Association

ARTICLES

Immunochemical detection of advanced glycation end products in renal cortex from STZ-induced diabetic rat

T Mitsuhashi, H Nakayama, T Itoh, S Kuwajima, S Aoki, T Atsumi and T Koike
2nd Department of Internal Medicine, Hokkaido University School of Medicine, Sapporo, Japan.

To reassess the accumulation of advanced glycation end products in diabetic renal cortex, we used a newly developed enzyme-linked immunosorbent assay to measure AGEs in renal cortex from STZ-induced diabetic and age-matched control rats. Kidneys and aortas were obtained from rats after 5 and 20 wk of STZ injection. At 5 wk of diabetes, the mean AGE content in collagenase-digested materials of renal cortex was > 16-fold higher in diabetic animals compared with controls (1044.4 +/- 151.8 vs. 64.3 +/- 5.7 arbitrary units, P < 0.01). At 20 wk of diabetes, it was > 45-fold higher in diabetic compared with control animals (3841.0 +/- 1077.3 vs. 83.8 +/- 12.8 AUs, P < 0.01). These increases were surprisingly large compared with the < 1.5-fold increase in the fluorescence levels both after 5 and 20 wk of diabetes. In control animals, neither the AGE content nor the fluorescence level increased during this period. Moreover, at 20 wk of diabetes, the AGE content was 39-fold higher in renal cortex compared with aorta. This study provided the first immunochemical evidence that collagenase-digested materials of renal cortex, as well as aorta, contained AGE products and that these products were present in much higher levels in diabetic animals than in control animals. With duration of diabetes, the AGE contents increased significantly both in renal cortex and aorta. The excessive accumulation of AGEs was most apparent in the diabetic kidney.(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Baidoshvili, P.A.J. Krijnen, K. Kupreishvili, C. Ciurana, W. Bleeker, R. Nijmeijer, C.A. Visser, F.C. Visser, C.J.L.M. Meijer, W. Stooker, et al. N{epsilon}-(Carboxymethyl)lysine Depositions in Intramyocardial Blood Vessels in Human and Rat Acute Myocardial Infarction: A Predictor or Reflection of Infarction? Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2497 - 2503. [Abstract] [Full Text] [PDF]

				N. Nakano, K. Fukuhara-Takaki, T. Jono, K. Nakajou, N. Eto, S. Horiuchi, M. Takeya, and R. Nagai Association of Advanced Glycation End Products with A549 Cells, a Human Pulmonary Epithelial Cell Line, Is Mediated by a Receptor Distinct from the Scavenger Receptor Family and RAGE. J. Biochem., May 1, 2006; 139(5): 821 - 829. [Abstract] [Full Text] [PDF]

				E. Sato, F. Mori, S. Igarashi, T. Abiko, M. Takeda, S. Ishiko, and A. Yoshida Corneal Advanced Glycation End Products Increase in Patients With Proliferative Diabetic Retinopathy Diabetes Care, March 1, 2001; 24(3): 479 - 482. [Abstract] [Full Text]

				S. Amano, Y. Kaji, T. Oshika, T. Oka, R. Machinami, R. Nagai, and S. Horiuchi Advanced glycation end products in human optic nerve head Br. J. Ophthalmol., January 1, 2001; 85(1): 52 - 55. [Abstract] [Full Text]

				M. B. Davidson, D. L. Schriger, A. L. Peters, and B. Lorber Relationship Between Fasting Plasma Glucose and Glycosylated Hemoglobin: Potential for False-Positive Diagnoses of Type 2 Diabetes Using New Diagnostic Criteria JAMA, April 7, 1999; 281(13): 1203 - 1210. [Abstract] [Full Text] [PDF]

				H. Shoda, S. Miyata, B.-F. Liu, H. Yamada, T. Ohara, K. Suzuki, M. Oimomi, and M. Kasuga Inhibitory Effects of Tenilsetam on the Maillard Reaction Endocrinology, May 1, 1997; 138(5): 1886 - 1892. [Abstract] [Full Text] [PDF]

				S. Miyata, B.-F. Liu, H. Shoda, T. Ohara, H. Yamada, K. Suzuki, and M. Kasuga Accumulation of Pyrraline-modified Albumin in Phagocytes due to Reduced Degradation by Lysosomal Enzymes J. Biol. Chem., February 14, 1997; 272(7): 4037 - 4042. [Abstract] [Full Text] [PDF]

				Y. Al-Abed, H. Liebich, W. Voelter, and R. Bucala Hydroxyalkenal Formation Induced by Advanced Glycosylation of Low Density Lipoprotein J. Biol. Chem., February 9, 1996; 271(6): 2892 - 2896. [Abstract] [Full Text] [PDF]

				G. Hasegawa, A. J. Hunter, and A. S. Charonis Matrix Nonenzymatic Glycosylation Leads to Altered Cellular Phenotype and Intracellular Tyrosine Phosphorylation J. Biol. Chem., February 17, 1995; 270(7): 3278 - 3283. [Abstract] [Full Text] [PDF]

				N. Ohgami, R. Nagai, M. Ikemoto, H. Arai, A. Kuniyasu, S. Horiuchi, and H. Nakayama CD36, a Member of the Class B Scavenger Receptor Family, as a Receptor for Advanced Glycation End Products J. Biol. Chem., January 26, 2001; 276(5): 3195 - 3202. [Abstract] [Full Text] [PDF]

				N. Ohgami, R. Nagai, A. Miyazaki, M. Ikemoto, H. Arai, S. Horiuchi, and H. Nakayama Scavenger Receptor Class B Type I-mediated Reverse Cholesterol Transport Is Inhibited by Advanced Glycation End Products J. Biol. Chem., April 13, 2001; 276(16): 13348 - 13355. [Abstract] [Full Text] [PDF]